A journey to produce platelets in vitro

Transfusion

Volumn 51, Issue SUPPL. 4, 2011, Pages

  Reems, Jo Anna ^a  

^a PUGET SOUND BLOOD CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; THROMBOCYTE CONCENTRATE;

ARTICLE; BIOGENESIS; BIOREACTOR; CELL DIFFERENTIATION; CELL EXPANSION; CELL LINEAGE; HUMAN; MEGAKARYOCYTE; REGULATORY MECHANISM; THROMBOCYTE; THROMBOCYTE FUNCTION;

ANTIGENS, HUMAN PLATELET; BIOREACTORS; BLOOD PLATELETS; CELL CULTURE TECHNIQUES; CELL SEPARATION; CELLS, CULTURED; CULTURE MEDIA; CYTOKINES; HEMATOPOIETIC STEM CELLS; HUMANS; MEGAKARYOCYTES; PLATELET TRANSFUSION; THROMBOPOIESIS; THROMBOPOIETIN;

EID: 81055125403     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2011.03380.x     Document Type: Article

References (54)

1. Slichter SJ, Bolgiano D, Corson J, Jones MK, Christoffel T,. Extended storage of platelet-rich plasma-prepared platelet concentrates in plasma or Plasmalyte. Transfusion 2010; 50: 2199-209.
2. Gupta A, Chandra T, Kumar A,. In vitro function of random donor platelets stored for 7 days in composol platelet additive solution. Asian J Transfus Sci 2011; 5: 11-4.
3. Sandgren P, Mayaudon V, Payrat JM, Sjödin A, Gulliksson H,. Storage of buffy-coat-derived platelets in additive solutions: in vitro effects on platelets stored in reformulated PAS supplied by a 20% plasma carry-over. Vox Sang 2010; 98 (Pt 2): 415-22.
4. Johnson LN, Winter KM, Reid S, Hartkopf-Theis T, Marks DC,. Cryopreservation of buffy-coat-derived platelet concentrates in dimethyl sulfoxide and platelet additive solution. Cryobiology 2011; 62: 100-6.
5. Reems JA, Pineault N, Sun S,. In vitro megakaryocyte production and platelet biogenesis: state of the art. Transfus Med Rev 2010; 24: 33-43.
6. Long MW, Hoffman R, Benz EJ Jr, Shattil SJ, Furie B, Cohen HJ, Silberstein LE, McGlave P,. Thrombocytopoiesis. In:, Hoffman R, Benz EJ Jr, Shattil SJ, Furie B, Cohen HJ, editors. Hematology basic principles and practice. 3rd ed. New York: Churchill Livingstone; 2000. p. 245-60.
7. Lord BI, Testa NG, Hendry JH,. The relative spatial distributions of CFUs and CFUc in the normal mouse femur. Blood 1975; 46: 65-72.
8. Vitrat N, Cohen-Solal K, Pique C, Le Couedic JP, Norol F, Larsen AK, Katz A, Vainchenker W, Debili N,. Endomitosis of human megakaryocytes are due to abortive mitosis. Blood 1998; 91: 3711-23. (Pubitemid 28225739)
9. Lordier L, Jalil A, Aurade F, Larbret F, Larghero J, Debili N, Vainchenker W, Chang Y,. Megakaryocyte endomitosis is a failure of late cytokinesis related to defects in the contractile ring and Rho/Rock signaling. Blood 2008; 112: 3164-74.
10. Italiano JE Jr, Shivdasani RA,. Megakaryocytes and beyond: the birth of platelets. J Thromb Haemost 2003; 1: 1174-82.
11. Becker RP, De Bruyn PP,. The transmural passage of blood cells into myeloid sinusoids and the entry of platelets into the sinusoidal circulation; a scanning electron microscopic investigation. Am J Anat 1976; 145: 183-205.
12. Schulze H, Korpal M, Hurov J, Kim SW, Zhang J, Cantley LC, Graf T, Shivdasani RA,. Characterization of the megakaryocyte demarcation membrane system and its role in thrombopoiesis. Blood 2006; 107: 3868-75. (Pubitemid 43726790)
13. Junt T, Schulze H, Chen Z, Massberg S, Goerge T, Krueger A, Wagner DD, Graf T, Italiano JE Jr, Shivdasani RA, von Andrian UH,. Dynamic visualization of thrombopoiesis within bone marrow. Science 2007; 317: 1767-70. (Pubitemid 47461844)
14. Zucker-Franklin D, Petursson S,. Thrombocytopoiesis-analysis by membrane tracer and freeze-fracture studies on fresh human and cultured mouse megakaryocytes. J Cell Biol 1984; 99: 390-402. (Pubitemid 14065165)
15. Zucker-Franklin D, Philipp CS,. Platelet production in the pulmonary capillary bed: new ultrastructural evidence for an old concept. Am J Pathol 2000; 157: 69-74. (Pubitemid 30641726)
16. Kosaki G,. In vivo platelet production from mature megakaryocytes: does platelet release occur via proplatelets? Int J Hematol 2005; 81: 208-19. (Pubitemid 41364486)
17. Chang Y, Bluteau D, Debili N, Vainchenker W,. From hematopoietic stem cells to platelets. J Thromb Haemost 2007; 5 Suppl 1: 318-27. (Pubitemid 46958849)
18. Ayala IA, Tomer A, Kellar KL,. Flow cytometric analysis of megakaryocyte-associated antigens on CD34 cells and their progeny in liquid culture. Stem Cells 1996; 14: 320-9. (Pubitemid 26161614)
19. Choi ES, Nichol JL, Hokom MM, Hornkohl AC, Hunt P,. Platelets generated in vitro from proplatelet-displaying human megakaryocytes are functional. Blood 1995; 85: 402-13.
20. Proulx C, Boyer L, Hurnanen DR, Lemieux R,. Preferential ex vivo expansion of megakaryocytes from human cord blood CD34+-enriched cells in the presence of thrombopoietin and limiting amounts of stem cell factor and Flt-3 ligand. J Hematother Stem Cell Res 2003; 12: 179-88. (Pubitemid 36529569)
21. Fujimoto TT, Kohata S, Suzuki H, Miyazaki H, Fujimura K,. Production of functional platelets by differentiated embryonic stem (ES) cells in vitro. Blood 2003; 102: 4044-51. (Pubitemid 37486987)
22. Takayama N, Nishikii H, Usui J, Tsukui H, Sawaguchi A, Hiroyama T, Eto K, Nakauchi H,. Generation of functional platelets from human embryonic stem cells in vitro via ES-sacs, VEGF-promoted structures that concentrate hematopoietic progenitors. Blood 2008; 111: 5298-306.
23. Matsunaga T, Tanaka I, Kobune M, Kawano Y, Tanaka M, Kuribayashi K, Iyama S, Sato T, Sato Y, Takimoto R, Takayama T, Kato J, Ninomiya T, Hamada H, Niitsu Y,. Ex vivo large-scale generation of human platelets from cord blood CD34+ cells. Stem Cells 2006; 24: 2877-87. (Pubitemid 46053024)
24. Lu SJ, Li F, Yin H, Feng Q, Kimbrel EA, Hahm E, Thon JN, Wang W, Italiano JE, Cho J, Lanza R,. Platelets generated from human embryonic stem cells are functional in vitro and in the microcirculation of living mice. Cell Res 2011; 21: 530-45.
25. Gandhi MJ, Drachman JG, Reems JA, Thorning D, Lannutti BJ,. A novel strategy for generating platelet-like fragments from megakaryocytic cell lines and human progenitor cells. Blood Cells Mol Dis 2005; 35: 70-3. (Pubitemid 40922777)
26. Robert A, Boyer L, Pineault N,. Glycoprotein ibalpha receptor instability is associated with loss of quality in platelets produced in culture. Stem Cells Dev 2011; 20: 379-90.
27. Sullenbarger B, Bahng JH, Gruner R, Kotov N, Lasky LC,. Prolonged continuous in vitro human platelet production using three-dimensional scaffolds. Exp Hematol 2009; 37: 101-10.
28. Lansdorp PM, Dragowska W, Mayani H,. Ontogeny-related changes in proliferative potential of human hematopoietic cells. J Exp Med 1993; 178: 787-91. (Pubitemid 23260416)
29. Kohler T, Plettig R, Wetzstein W, Schaffer B, Ordemann R, Nagels HO, Ehninger G, Bornhäuser M,. Defining optimum conditions for the ex vivo expansion of human umbilical cord blood cells. Influences of progenitor enrichment, interference with feeder layers, early-acting cytokines and agitation of culture vessels. Stem Cells 1999; 17: 19-24. (Pubitemid 29063685)
30. Briddell RA, Kern BP, Zilm KL, Stoney GB, McNiece IK,. Purification of CD34+ cells is essential for optimal ex vivo expansion of umbilical cord blood cells. J Hematother 1997; 6: 145-50.
31. Poloni A, Giarratana MC, Firat H, Kobari L, Gorin NC, Douay L,. The ex vivo expansion capacity of normal human bone marrow cells is dependent on experimental conditions: role of the cell concentration, serum and CD34+ cell selection in stroma-free cultures. Hematol Cell Ther 1997; 39: 49-58. (Pubitemid 27309264)
32. Case J, Rice A, Vowels M,. Cytokine mediated expansion of human umbilical cord blood CD34+ cells: comparison of the use of partially purified and pure CD34+ target cells. Hematol Cell Ther 1997; 39: 193-7. (Pubitemid 27414653)
33. Xu R, Medchill M, Reems JA,. Serum supplement, inoculum cell density, and accessory cell effects are dependent on the cytokine combination selected to expand human HPCs ex vivo. Transfusion 2000; 40: 1299-307.
34. Piacibello W, Sanavio F, Garetto L, Severino A, Bergandi D, Ferrario J, Fagioli F, Berger M, Aglietta M,. Extensive amplification and self-renewal of human primitive hematopoietic stem cells from cord blood. Blood 1997; 89: 2644-53. (Pubitemid 27172548)
35. Piacibello W, Sanavio F, Garetto L, Severino A, Dané A, Gammaitoni L, Aglietta M,. Differential growth factor requirement of primitive cord blood hematopoietic stem cell for self-renewal and amplification vs. proliferation and differentiation. Leukemia 1998; 12: 718-27. (Pubitemid 28220825)
36. Xu R, Reems JA,. Umbilical cord blood progeny cells that retain a CD34+ phenotype after ex vivo expansion have less engraftment potential than unexpanded CD34+ cells. Transfusion 2001; 41: 213-8. (Pubitemid 32220512)
37. New York Council on Human Blood and Transfusions Services. Guidelines for the administration of platelets. 2nd ed. New York: New York Council on Human Blood and Transfusions Services; 2006. p. 1-8. [cited 2011 Sep 4]. Available from: URL
38. Wada RK, Bradford A, Moogk M, Yim R, Strong DM, Drachman J, Reems JA,. Cord blood units collected at a remote site: a collaborative endeavor to collect umbilical cord blood through the Hawaii Cord Blood Bank and store the units at the Puget Sound Blood Center. Transfusion 2004; 44: 111-8. (Pubitemid 38177145)
39. Kaufman RM, Airo R, Pollack S, Crosby WH,. Circulating megakaryocytes and platelet release in the lung. Blood 1965; 26: 720-31.
40. Shim MH, Hoover A, Blake N, Drachman JG, Reems JA,. Gene expression profile of primary human CD34+CD38lo cells differentiating along the megakaryocyte lineage. Exp Hematol 2004; 32: 638-48. (Pubitemid 38891533)
41. Lannutti BJ, Shim MH, Blake N, Reems JA, Drachman JG,. Identification and activation of Src family kinases in primary megakaryocytes. Exp Hematol 2003; 31: 1268-74. (Pubitemid 37510033)
42. Komatsu N, Kunitama M, Yamada M, Hagiwara T, Kato T, Miyazaki H, Eguchi M, Yamamoto M, Miura Y,. Establishment and characterization of the thrombopoietin-dependent megakaryocytic cell line UT-7/TPO. Blood 1996; 87: 4552-60. (Pubitemid 26000291)
43. Orth JD, McNiven MA,. Dynamin at the actin-membrane interface. Curr Opin Cell Biol 2003; 15: 31-9. (Pubitemid 36044712)
44. Reems JA, Wang W, Tsubata K, Abdurrahman N, Sundell B, Tijssen MR, van der Schoot E, Di Summa F, Patel-Hett S, Italiano J Jr, Gilligan DM,. Dynamin 3 participates in the growth and development of megakaryocytes. Exp Hematol 2008; 36: 1714-27.
45. Wang W, Gilligan DM, Sun S, Wu X, Reems JA,. Distinct functional effects for dynamin3 during megakaryocytopoiesis. Stem Cells Dev 2011. [Epub ahead of print].
46. Kelley MJ, Jawien W, Ortel TL, Korczak JF,. Mutation of MYH9, encoding non-muscle myosin heavy chain A, in May-Hegglin anomaly. Nat Genet 2000; 26: 106-8.
47. Seri M, Cusano R, Gangarossa S, Caridi G, Bordo D, Lo Nigro C, Ghiggeri GM, Ravazzolo R, Savino M, Del Vecchio M, Apolito M, Iolascon A, Zelante LL, Savoia A, Balduini CL, Noris P, Magrini U, Belletti S, Heath KE, Babcock M, Glucksman MJ, Aliprandis E, Bizzaro N, Desnick RJ, Martignetti JA,. Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and Sebastian syndromes. The May-Hegglin/Fechtner Syndrome Consortium. Nat Genet 2000; 26: 103-5.
48. Lannutti BJ, Blake N, Gandhi MJ, Reems JA, Drachman JG,. Induction of polyploidization in leukemic cell lines and primary bone marrow by Src kinase inhibitor SU6656. Blood 2005; 105: 3875-8. (Pubitemid 40656131)
49. Broudy VC, Lin NL,. AMG531 stimulates megakaryopoiesis in vitro by binding to Mpl. Cytokine 2004; 25: 52-60. (Pubitemid 38018897)
50. Shin JW, Swift J, Spinler KR, Discher DE,. Myosin-II inhibition and soft 2D matrix maximize multinucleation and cellular projections typical of platelet-producing megakaryocytes. Proc Natl Acad Sci U S A 2011; 108: 11458-63.
51. Rafii S, Shapiro F, Pettengell R, Ferris B, Nachman RL, Moore MA, Asch AS,. Human bone marrow microvascular endothelial cells support long-term proliferation and differentiation of myeloid and megakaryocytic progenitors. Blood 1995; 86: 3353-63.
52. Han P, Guo XH, Story CJ,. Enhanced expansion and maturation of megakaryocytic progenitors by fibronectin. Cytotherapy 2002; 4: 277-83.
53. Arnhold S, Klein H, Semkova I, Addicks K, Schraermeyer U,. Neurally selected embryonic stem cells induce tumor formation after long-term survival following engraftment into the subretinal space. Invest Ophthalmol Vis Sci 2004; 45: 4251-5. (Pubitemid 39564646)
54. Dunois-Larde C, Capron C, Fichelson S, Bauer T, Cramer-Bordé E, Baruch D,. Exposure of human megakaryocytes to high shear rates accelerates platelet production. Blood 2009; 114: 1875-83.